- US-listed companies
- Organogenesis Holdings Inc.
- Income statement
Organogenesis Holdings Inc.ORGO
Market cap
$655.83M
P/E ratio
| 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | - | - | 193 | 261 | 338 | 468 | 451 | 433 | 482 |
| Revenue growth (%) | - | - | - | ||||||
| Cost of revenue | - | - | 69 | 76 | 87 | 114 | 105 | 106 | 116 |
| Gross profit | - | - | 125 | 185 | 251 | 354 | 346 | 327 | 366 |
| Gross margin (%) | - | - | |||||||
| Research & development | - | - | 11 | 15 | 20 | 31 | 40 | 44 | 50 |
| Selling, general & administrative | - | - | 162 | 200 | 203 | 250 | 284 | 270 | 295 |
| Operating margin (%) | - | - | |||||||
| Operating income | - | -4,591,834 | -52 | -29 | 27 | 73 | 22 | 13 | -1 |
| Operating expenses | 208,698 | 5 | 176 | 214 | 224 | 281 | 324 | 314 | 368 |
| Income before tax | - | - | -65 | -40 | 18 | 64 | 20 | 10 | -3 |
| Pretax margin (%) | - | - | -33.5 | -15.4 | 5.5 | 13.6 | 4.5 | 2.4 | -0.6 |
| Provision for income taxes | - | - | 0 | 0 | 1 | -31 | 5 | 5 | -4 |
| Effective tax rate (%) | - | - | |||||||
| Net income | -208,698 | -2,093,913 | -65 | -40 | 18 | 95 | 16 | 5 | 1 |
| Net income margin (%) | - | - | |||||||
| Earnings per share | - | - | - | - | 0.17 | 0.74 | 0.12 | 0.04 | -0.01 |
| Diluted EPS | - | - | - | - | 0.16 | 0.71 | 0.12 | 0.04 | -0.01 |
| EBITDA | - | - | - | - | - | - | - | - | |
| EBITDA margin (%) | - | - | - | - | - | - | - | - |